Morgan Stanley
IMNN icon

Morgan Stanley’s Imunon IMNN Stock Holding History

Morgan Stanley’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.92K Buy
3,035
+71
+2% +$234 ﹤0.01% 6982
2025
Q4 		$11.3K Sell
2,964
-1,545
-34% -$6.61K ﹤0.01% 6863
2025
Q3 		$23.1K Buy
4,509
+4,384
+3,507% +$29.3K ﹤0.01% 6644
2025
Q2 		$1.3K Hold
125
– – ﹤0.01% 7299
2025
Q1 		$1.71K Hold
125
– – ﹤0.01% 7201
2024
Q4 		$1.55K Sell
125
-38
-23% -$439 ﹤0.01% 7234
2024
Q3 		$2.26K Buy
163
+38
+30% +$602 ﹤0.01% 7105
2024
Q2 		$1.89K Hold
125
– – ﹤0.01% 7075
2024
Q1 		$2.67K Sell
125
-125
-50% -$1.19K ﹤0.01% 7024
2023
Q4 		$2.22K Buy
250
+125
+100% +$1.52K ﹤0.01% 7125
2023
Q3 		$1.6K Hold
125
– – ﹤0.01% 7165
2023
Q2 		$2.1K Hold
125
– – ﹤0.01% 7182
2023
Q1 		$2.02K Sell
125
-16
-11% -$308 ﹤0.01% 7234
2022
Q4 		$2.48K Hold
141
– – ﹤0.01% 7314
2022
Q3 		$3K Sell
141
-30
-18% -$842 ﹤0.01% 7385
2022
Q2 		$4K Sell
171
-30
-15% -$1.1K ﹤0.01% 7448
2022
Q1 		$13K Buy
201
+28
+16% +$2.2K ﹤0.01% 7311
2021
Q4 		$18K Sell
173
-11,747
-99% -$1.83M ﹤0.01% 7250
2021
Q3 		$2.16M Buy
11,920
+3,679
+45% +$764K ﹤0.01% 4508
2021
Q2 		$2.05M Sell
8,241
-1,686
-17% -$399K ﹤0.01% 4612
2021
Q1 		$2.68M Buy
9,927
+9,871
+17,627% +$3.32M ﹤0.01% 4029
2020
Q4 		$8K Sell
56
-3,393
-98% -$407K ﹤0.01% 6690
2020
Q3 		$494K Buy
3,449
+3,447
+172,350% +$871K ﹤0.01% 4651
2020
Q2 		$1K Buy
2
+1
+100% +$434 ﹤0.01% 6518
2020
Q1 		$0 Sell
1
-2
-67% -$501 ﹤0.01% 6624
2019
Q4 		$1K Hold
3
– – ﹤0.01% 6566
2019
Q3 		$1K Buy
3
+1
+50% +$342 ﹤0.01% 6547
2019
Q2 		$1K Hold
2
– – ﹤0.01% 6543
2019
Q1 		$1K Sell
2
-2
-50% -$829 ﹤0.01% 6516
2018
Q4 		$2K Buy
4
+1
+33% +$415 ﹤0.01% 6417
2018
Q3 		$1K Sell
3
-66
-96% -$36.4K ﹤0.01% 6626
2018
Q2 		$39K Buy
69
+64
+1,280% +$31.7K ﹤0.01% 5976
2018
Q1 		$2K Hold
5
– – ﹤0.01% 6496
2017
Q4 		$3K Buy
5
+3
+150% +$1.7K ﹤0.01% 6399
2017
Q3 		$1K Sell
2
-3
-60% -$924 ﹤0.01% 6446
2017
Q2 		$2K Buy
5
+2
+67% +$1.28K ﹤0.01% 6457
2017
Q1 		$3K Buy
3
+1
+50% +$859 ﹤0.01% 6421
2016
Q4 		$2K Buy
+2
New +$4.57K ﹤0.01% 6382
2016
Q3 		– Sell
-1
Closed -$3.42K – 6528
2016
Q2 		$4K Hold
1
– – ﹤0.01% 6259
2016
Q1 		$4K Sell
1
-5
-83% -$19K ﹤0.01% 6319
2015
Q4 		$33K Buy
6
+5
+500% +$25.7K ﹤0.01% 5872
2015
Q3 		$4K Sell
1
-16
-94% -$95.5K ﹤0.01% 6416
2015
Q2 		$108K Buy
17
+11
+183% +$78.1K ﹤0.01% 5543
2015
Q1 		$42K Sell
6
-11
-65% -$76.5K ﹤0.01% 5854
2014
Q4 		$109K Buy
17
+1
+6% +$6.94K ﹤0.01% 5512
2014
Q3 		$129K Sell
16
-2
-11% -$17.4K ﹤0.01% 5358
2014
Q2 		$171K Buy
18
+2
+13% +$17.9K ﹤0.01% 5243
2014
Q1 		$150K Hold
16
– – ﹤0.01% 5256
2013
Q4 		$173K Buy
16
+10
+167% +$120K ﹤0.01% 5093
2013
Q3 		$80K Buy
6
+1
+20% +$14.8K ﹤0.01% 5137
2013
Q2 		$60K Buy
+5
New +$69.6K ﹤0.01% 5174

Other funds holding IMNN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Morgan Stanley's IMNN Position: Q1 2026 in Review

Morgan Stanley increased its Imunon (IMNN) stake by 2.4% in Q1 2026, buying an estimated $234 and bringing the position to 3,035 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #6982.

Morgan Stanley first reported a position in IMNN in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.68M in Q1 2021. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

  • Morgan Stanley held 3,035 shares of Imunon worth $8.92K as of Q1 2026.
  • Morgan Stanley bought 71 Imunon shares in Q1 2026, an estimated $234.
  • Imunon made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6982 holding.
  • Morgan Stanley first reported a position in Imunon in Q2 2013 and has held it in 51 quarters since.
  • Morgan Stanley's Imunon position peaked at $2.68M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.